Type I interferons (IFN-a and IFN-P) were originally described as potent an
tiviral substances, which are produced upon infection of animal cells with
viruses. Despite a large body of literature that has accumulated during the
past 25 years, their regulatory function in the immune system is still muc
h less appreciated. Recent studies have highlighted the production of type
I IFNs, their function in the immune response to infectious agents and the
target cells of these interferons. Type IIFNs clearly affect the release of
proinflammatory cytokines or nitric oxide by dendritic cells and macrophag
es, the capacity of type II interferon (IFN-gamma) to activate phagocytes,
the differentiation of T helper cells and the innate control of non-viral p
athogens.